NewsSTAT
Ranked by formulaVerdict: RoutineSTAT+: Tango builds on Revolution Medicines' pancreatic cancer success
As the ESMO conference kicks off, Tango's pancreatic cancer combination shows striking promise and detailed data on Moderna and Merck's cancer vaccine is released early.
Score█████░░░░░5.1
VerdictCompetent work. Briefs at most.
Summary from the source
As the ESMO conference kicks off, Tango's pancreatic cancer combination shows striking promise and detailed data on Moderna and Merck's cancer vaccine is released early.
The editor's rubric
- Leverage2 / 5
- Reusable within one subfield (a technique, dataset, or protocol a few groups will adopt).
- Magnitude2 / 5
- Solid incremental gain on a meaningful problem.
- Evidence2 / 5
- Limited: single setting, weak baselines, or an observational association presented as causal.
- Novelty2 / 5
- A new combination of known ideas.
- Trajectory2 / 5
- Some room to improve with obvious engineering.
- Stakes3 / 5
- Meaningful benefit to many people within a few years.
Editor’s rationale
Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: verification (error bars); stakes (major disease, prevention or cure).
How the score was computed
Score█████░░░░░5.1
Desks place stronger verdicts first, then use this score to order work within the same verdict.
- Merit
- 3.8 / 10
- Adjusted merit
- 3.9 / 10
- Attention
- 28%
- Freshness
- 98%